Patients with breast cancer, colorectal cancer, oesophageal cancer and pancreatic adenocarcinoma. research hub

A Phase I study to evaluate the safety and dosimetry of 68Ga-labelled OncoFAP derivatives in patients with solid tumors

This early-stage study is testing a new way to find certain cancers, like breast or bowel cancer, using a special scan. Researchers want to check if a new substance called 68Ga-OncoFAP is safe and how much is needed for clear pictures in adults with these cancers.